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Objectives: to identify pre-operative factors that could predict complications following from transluminal repair of
abdominal aortic aneurysms (AAA).
Methods: during a 5-year period, 96 consecutive patients underwent elective endovascular treatment of a AAA. In all
patients, helical CT and/or Magnetic Resonance Imaging (MRI), and plain abdominal roentgenogram were performed at 1,
3, 6, 12, 18, and 24 months and yearly thereafter. Angiography was performed systematically 1 year after the stent-graft
implantation, or earlier if helical CT or MRI diagnosed an increase in the maximal transverse diameter or a high flow
endoleak.
Results: early (530 days) morbidity (12%) was significantly increased by pre-operative renal insufficiency (p5 0.01).
Early mortality (2%) correlated with ASA score (p 0.01). Median follow-up was 27 months (range 3±66). Mortality
(12%) during follow-up was correlated to the pre-operative coronary status (p 0.01). A type I endoleak was diagnosed in
18 patients (19%). Common iliac artery diameter was correlated with the presence of type I endoleak (p5 0.001). A type II
endoleak was diagnosed in 47 (49%) patients. The diagnostic of type II endoleak was significantly increased (p 0.001) in
patients with pre-operative patent IMA associated with more than four patent lumbar arteries.
The anatomic characteristics of the aneurysm were correlated to the additional endovascular procedures during stent-
graft implantation (p 0.01), and to the implantation of a complementary iliac limb extension during follow-up (p 0.01).
Conclusions: the risk factors determined by this statistical analysis could help surgeons to select more accurately patients
suitable for endovascular treatment.
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Technical success and early favourable outcomes
reported after endovascular treatment of abdominal
aortic aneurysms (AAA) by stentgraft implantation
has contributed to the enthusiasm for this method.1
According to early results, the endovascular treatment
has emerged as a method of repair which is less inva-
sive compared to open surgery. Initial endovascular
experience was limited by AAA morphology.2 New
devices have been developed to expand stent-graft
implantation indication.3 Data from series with
medium and long-term follow-up are progressively
reported.4,5 Endoleaks, the persistence of blood
flow outside the stent-graft lumen, but within the
aneurysm sac, resulting in incomplete exclusion ofPlease address all correspondence to: S. Haulon, Department of
Vascular Surgery, HoÃpital Cardiologique, CHRU de Lille, 59037 Lille
Cedex, France. E-mail: haulon@ccf.org
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nosed with rates up to 450%.6 This persistent peri-
graft blood flow can occur from the proximal and
distal (type I endoleaks) or midgraft (type III endo-
leaks) segments of the stent-graft, or from retrograde
flow into the aneurysm sac by feeding vessels arising
from the lumbar arteries or from the inferior
mesenteric artery (type II endoleaks).7,8 Complications
concerning the stent-graft device integrity are also
reported. These include structural alteration, limb
kinking and thrombosis secondary to the longitudinal
shrinkage of the excluded aneurysmal sac or to graft
migration. Secondary interventions are frequently
necessary to maintain stent-graft patency and
aneurysm exclusion.9±12
We prospectively analysed 96 consecutive endo-
vascular procedures for AAA exclusion to determine
statistically significant risk factors of complications
during stent-graft implantation, early, and late
follow-up.rights reserved.
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Patients
Between March 1996 and August 2001, 96 consecutive
patients with anatomical variables compatible for
endovascular treatment13 were selected for AAA treat-
ment (AAA maximum diameter 45 cm or increasing
40.5 cm in 6 months) in our institution. This repre-
sented 20% of the AAA treated in our institution
during this period. The population comprised 95
men and one woman, with a median age of 68 years
(range 46±85). Risk factors and American Society of
Anesthesiology (ASA) scores are reported in Table 1.
All pre-operative data and follow-up events were
prospectively entered into a database.
Anatomic characteristics of the aneurysms
The baseline assessment comprised a helical CT of the
abdomen and pelvis, and angiography of the abdo-
minal aorta and the lower limbs, with a calibration
catheter.
The anatomic characteristics of the proximal neck,
the aneurysm, and the right and left common iliac
arteries are reported in Table 2. Based on Eurostar
Registry criteria, 12 (13%) patients presented a type A
aneurysm, 48 (50%) a type B, 32 (33%) a type C, and 4
(4%) a type D.Table 1. Risk factors and ASA scores in the 96-patient cohort.
Patients %
Arterial hypertension 53 55
Diabetes 6 6
Coronary artery disease 58 60




Previous laparotomy 21 22
Obesity (weight 4110% ideal
body weight as per Lorenz)
24 25
ASA 1 3 3
ASA 2 26 27
ASA 3 50 52
ASA 4 17 18
Hypertension was defined as a history of high blood pressure
(exceeding 140/90 mm Hg) or the need for antihypertensive medi-
cation.
Coronary artery disease as documented coronary stenosis 450% or a
story of angina, myocardial infarction, or coronary artery angio-
plasty or bypass.
COPD (chronic obstructive pulmonary disease) as the need for
pharmacologic therapy for the treatment of chronic pulmonary
compromise or an forced expiratory volume in 1 s (FEV1) less than
75% of predicted value.
ASA, patient status according to the criteria of the American Society
of Anesthesiology.Inferior mesenteric artery (IMA) patency, defined as
visualization of this vessel in communication with the
aneurysm on pre-operative angiography, was diag-
nosed in 60 (63%) patients. The median number
of patent lumbar arteries, according to the same
definition, was 3 (range 0±8).
Stent-grafts
In 51 cases, a Vanguard1 prosthesis (Boston Scientific)
was implanted, in 20 cases an AneurRx1 prosthesis
(Medtronic), in 11 cases a Zenith1 prosthesis (Cook),
in eight cases a Talent1 prosthesis (Medtronic), and in
six cases a Stentor1 prosthesis (Mintec). The stent-
graft was bifurcated in 91 (95%) patients, tubular in
four (4%) patients, and degressive in one patient.
The stent-grafts were implanted by a conventional
transfemoral approach.14 Stent-grafts diameters were
determined by oversizing the CT scan proximal aortic
neck and iliac arteries diameters by 10±15%. In 14
(15%) patients, a common and/or external iliac
angioplasty stenting was performed (defined as
additional endovascular procedure during stent-graft
implantation).
Follow-up
In all patients, helical CT and/or Magnetic Resonance
Imaging (MRI), and plain abdominal roentgenogram
(PAR) were performed at 1, 3, 6, 12, 18, and 24 months
and yearly thereafter. MRI was not performed in the
12 patients with a Zenith1 prosthesis (Cook). Helical
CT and MRI were performed together to compare
both exams specificity and sensitivity for endoleak
detection.15
An angiography was scheduled systematically 12
months after the implantation of the stent-graft, or
earlier if helical CT or MRI diagnosed:
An increase of the aneurysm MTD, considered to
be significant when it was greater than the inter-
observer variability (42 mm).16
A type I endoleak.Table 2. Pre-operative anatomic characteristics of the aneurysms.
Median (range)
Diameter of the proximal neck 22 mm (16±28)
Length 25 mm (12±60)
Proximal neck angulation 10 (0±60)
Maximal transverse diameter 52 mm (45±71)
Diameter of the right common iliac arteries 13 mm (8±17)
Diameter of the left common iliac arteries 12 mm (7±19)
Right common iliac artery angulation 157 (90±175)
Left common iliac artery angulation 135 (75±175)
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described in a previous report.15 Angiograms were
performed in a dedicated numeric vascular suite
(Philips V3000, Best, Holland, or Toshiba, Tokyo,
Japan). MRI examinations were performed on a 1.5
Tesla Vision (Siemens, Erlanghen, Germany). Helical
CT scans were performed on a Somatom Plus 4A
(Siemens, Erlanghen, Germany) scanner.
The following parameters were determined:
Aneurysm MTD on helical CT.
Endoleaks and graft patency on helical CT, MRI and
angiograms.
Stent-graft limb kink (460) on PAR.
Statistical analysis
Quantitative values were expressed as median
with range values in brackets, qualitative ones as
frequencies.
Comparison of means have been performed with
the t-test or Wilcoxon test according to the sample
size and the assumption of normality. Comparisons
of frequencies have been performed using a Chi-
square or Fisher exact test.
Logistic regression was performed to identify pre-
operative risk factors. Decision trees were performed
with the CHAID (Chi-square Automatic Interaction
Detection) method in order to determine sub-groups
of patients with low or high risk of type II endoleak.
This non linear method was complementary with the
logistic linear regression method.
Mortality and freedom of type II endoleak
cumulative rates were assessed by lifetable methods.
A value of p5 0.05 was considered as statistically
significant.Table 3. Risk factors significantly inducing primary an
Event Risk factor
Early morbidity Renal insu
Early mortality ASA score
Late mortality Coronary
Respirator
Type I endoleak CIA diame
Distal type I endoleak CIA diame
Type II endoleak Patent IMA
Type II endoleak 44 patent
Type II endoleak Patent IMA
44 patent
Additional procedures during stent-graft CIA angul
implantation AAA anat
Secondary iliac limb extension during
follow-up
AAA anat
ASA score: patient status according to the criteria of the A
artery, AAA: abdominal aortic aneurysm, IMA: inferior
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Peri-operative period
Severe renal failure (creatinemia4 250 mmol/l) (n 5),
cardiac failure (n 2), myocardial infarction (n 1),
anemia (n 1), respiratory insufficiency (n 1), and
sigmoiditis (n 1) were observed in 11 patients (mor-
bidity: 12%). Early morbidity was significantly
increased by pre-operative renal insufficiency (creat-
inemia4 120 mmol/L). Post-operative renal failure
was always transient, and never required dialysis. It
was not correlated to the amount of periprocedural
contrast media. Results are summarized in Table 3.
During early follow-up (530 days), 2 patients died,
one from cardiac failure, and the other from myo-
cardial infarction. Early mortality (2%) was correlated
to the ASA score.
Follow-up
Median follow-up was 27 months (range 3±66). No
patient was lost to follow-up. Three patients were
followed up at another institution.
During follow-up, 11 patients (12%) died (Table 4),
from myocardial infarction (n 5), respiratory failure
(n 3), lung cancer (n 2), and pulmonary embolism
(n 1). Mortality during follow-up was correlated to
the pre-operative coronary status and respiratory
status (Table 3). The cumulative survival rates at 12,
24, and 36 months were respectively 98, 97, and 91%
(Fig. 1).
Helical CT or MRI diagnosed 18 type I endoleaks
(19%) during follow-up (Table 4), always con-
firmed by angiography. In 11 cases, it was a primaryd secondary events.
s Statistical method p value
fficiency Fisher exact 0.0035
Fisher exact 0.01
status Chi square 0.0114




lumbar arteries Chi square 0.0128
 Chi square 0.001
lumbar arteries
ation Wilcoxon 0.0181
omic characteristics Fisher exact 0.01
omic characteristics Fisher exact 0.0149
merican Society of Anesthesiology, CIA: common iliac
mesenteric artery.
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aortic neck) in three cases, and distal (iliac limb) in eight
cases. In seven cases, it was a secondary or late (430
days) endoleak, proximal in four cases, and distal in










0±12 91 13 9 2
12±24 77 2 18 1
24±36 54 2 16 4
436 21 1 4 6
Fig. 1. Cumulative survival rates assessed by lifetable methods.
Fig. 2. Type II endoleaks (T2) diagnosed by CT scan and/or MRI dur
status of the inferior mesenteric artery Patent lumbar arteries: nu
angiography.(proximal or distal) was performed in 9 patients to
treat the type I endoleak and is scheduled in 6 other
patients. The endoleak sealed spontaneously in three
patients.
The common iliac arteries diameters were corre-
lated with the presence of type I endoleaks and distal
type I endoleak (Table 3).
A type II endoleak was diagnosed by CTscan and/or
MRI in 47 (49%) patients (Table 4). CT scan alone diag-
nosed a type II endoleak in 22 (23%) patients.
In 8/47 patients (17%), the type II endoleak sealed
spontaneously during follow-up. In 18 patients, the
MTD shrinked despite the type II endoleak and no
complementary treatment was performed. In 21 (22%)
patients, presenting no aneurysm shrinkage 6 months
after the endoleak detection, an endovascular emboli-
zation was performed.
A patent pre-operative IMA increased significantly
the incidence of type II endoleak (Table 3). A type II
endoleak was diagnosed in 62% of patients with a
pre-operative patent IMA, and diagnosed in 29% of
patients without a pre-operative patent IMA. The
number of pre-operative patent lumbar arteries
increased also significantly the diagnostic of type II
endoleak. A type II endoleak was diagnosed in 82% of
patients with patent pre-operative IMA associated
with more than four patent lumbar arteries, and in
29% of patients without a pre-operative patent IMA
(Fig. 2). A logistic regression analysis demonstrated
that pre-operative patent IMA or lumbar arteries had
adjusted odds ratio respectively of 3.7 (95% CI: 1.5±9.2)ing follow-up. Patent/thrombosed IMA: pre-operative angiographic
mber (or4 4) of patent lumbar arteries on the pre-operative
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Fig. 3. Lifetable graph of freedom from type II endoleak.
122 S. Haulon et al.and 3.1 (95% CI: 1.1±9.3) for type II endoleak detec-
tion. The cumulative freedom of type II endoleak rates
at 12, 24, and 36 months were respectively 96, 77 and
46% (Fig. 3).
A type III endoleak was diagnosed in 6 (6%) pati-
ents. It was always treated by secondary implantation
of a covered stent.
A kink of an iliac limb of the stent-graft was diag-
nosed on PAR and CT scan in 34 (35%) patients and
was responsible for iliac limb thrombosis in eight (8%)
patients. A femoro-femoral cross over bypass was
performed in two patients, and an in situ thrombolysis
associated with complementary balloon expandable
stent implantation in the remaining six patients.
Angulations of the iliac artery increased significantly
additional endovascular procedures during stent-
graft implantation (Table 3).
The MTD at the end of follow-up, compared to the
pre-operative MTD, decreased in 48 (50%) patients,
remained unchanged in 47 (49%) patients, and
increased in one patient. The pre-operative MTD of
the AAA increased significantly additional endo-
vascular procedures during stent-graft implantation.
The anatomic characteristics of the aneurysm was also
correlated to the additional endovascular procedures
during stent-graft implantation (50% in type D aneu-
rysms, 17% in type A aneurysms), and to the implant-
ation of a complementary iliac limb extension during
follow-up (75% in type D aneurysms, 17% in type A
aneurysms).
Discussion
Early post-perative morbidity and mortality were
significantly influenced by the patients' pre-operative
status,17 especially the presence of multiple systemEur J Vasc Endovasc Surg Vol 25, February 2003disease.18 As for conventional open surgery, renal
insufficiency was a significant risk factor of early mor-
bidity.19,20 No correlation between post-operative
renal failure and the amount of periprocedural con-
trast media was demonstrated, probably because we
used very low doses, especially in patients with pre-
operative renal insufficiency. Endovascular treatment
is nonetheless probably the first choice treatment in
high risk patients, with favourable AAA anatomic
morphology, but the peri-operative management of
such patients requires adapted protocols and post-
operative surveillance in intensive care unit.
Mortality during follow-up (median 27 months)
was also significantly influenced by the pre-operative
patient's status, especially by the coronary status, and
the respiratory status. It has been already reported
that the long term mortality rate of patients under-
going surgical repair of AAA is significantly higher
compared with an aged match population. A major
reason for that is the high incidence of risk factors in
the AAA population.21
This study confirmed that the most frequent endo-
leaks seems to be type II endoleaks.22,23 A higher rate
of type II endoleaks (50%) was observed compared to
other series. This high rate of type II endoleaks may be
explained by our specific follow-up using magnetic
resonance in addition to helical CT.16 This exam is
considered as the most sensitive for type II endoleaks
location.24 We would report a 23% rate of type II
endoleaks if we considered only those diagnosed by
CT scan. Pre-operative patency of the IMA25 and the
number of patent lumbar arteries26 influenced signifi-
cantly the diagnosis of type II endoleaks, especially
when associated with44 pre-operative patent lumbar
arteries (p 0.001).
The rate of type I endoleak we reported (19%) is also
higher than other series. As these are high flow endo-
leaks, they can be diagnosed by a routine imaging
follow-up,27 performed either by duplex scan, helical
CT, or MRI. Therefore the frequent use of MRI during
follow-up did not influence this high rate. Follow-
up did influence detection of type I endoleaks,
because 7/18 (39%) were secondary endoleaks. The
rate of primary type I endoleaks was 12%, which we
attribute to the sizing errors incurred at the beginning
of our experience.28 The secondary endoleaks resulted
from migration and deformation of the prosthesis29
due to the aneurysm retraction, or from the aneurys-
mal evolution of the aortic neck and the iliac arteries.
The diameter of the implantation site of the stent-
graft on the iliac arteries influenced significantly dur-
ing follow-up the diagnostic of type I endoleak. This
result advocate the necessity of implanting the distal
end of the iliac limbs as far as possible, in healthy iliac
Risk Factors in Endovascular Aneurysm Repair 123arteries segments, ideally just above the iliac bifur-
cation.3 The implantation zone can be the external
iliac artery when necessary, after embolization of the
internal iliac artery, if the controlateral internal iliac
artery remains patent. We recommend, as for the
proximal neck, oversizing the stent-graft's iliac limbs
by 410%. Manufacturers now provide extensions
with diameters up to 22 mm to exclude efficiently
ectasic iliac arteries. The combination of extensive
and oversize stent-grafting will probably decrease
distal type I endoleaks by device migration or
aneurysm evolution, by limiting AAA longitudinal
shrinkage and anticipating artery diameter changes.
The pre-operative anatomic characteristics of the
AAA is a major factor influencing adverse events dur-
ing follow-up.6 The aneurysm propagation, according
to the Eurostar Registry criteria, had equivalent influ-
ence on peri and post-operative complications.
The results of our study should be interpreted caut-
iously because nearly 60% of the devices employed
are first generation devices no more commercially
available. A comparison of the results between the
first and second generation devices will be interesting
when sufficient follow-up of second generation
devices will be available.
The data from our series confirms the important
number of adverse events after endovascular exclu-
sion of AAA. To prevent AAA rupture, a close life
time follow-up is necessary, especially in patients pre-
senting risk factors for secondary procedures.
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